AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Plaque-type Psoriasis

In brief

The purpose of this study was to provide long term clinical data for the compound for the treatment of the indication of moderate to severe chronic plaque-type psoriasis.

Key facts

Study ID

NCT01132612

Run by

Novartis Pharmaceuticals

People needed

275

Starts

2010-05-11

Expected to finish

2016-10-18

Last updated by the study team

2018-01-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — Little Rock, Arkansas, United States
• Novartis Investigative Site — Pasadena, California, United States
• Novartis Investigative Site — San Diego, California, United States
• Novartis Investigative Site — Newnan, Georgia, United States
• Novartis Investigative Site — Snellville, Georgia, United States
• Novartis Investigative Site — Champaign, Illinois, United States
• Novartis Investigative Site — Springfield, Illinois, United States
• Novartis Investigative Site — Evansville, Indiana, United States
• Novartis Investigative Site — Topeka, Kansas, United States
• Novartis Investigative Site — Louisville, Kentucky, United States
• Novartis Investigative Site — Clinton Township, Michigan, United States
• Novartis Investigative Site — Detroit, Michigan, United States
• Novartis Investigative Site — Minneapolis, Minnesota, United States
• Novartis Investigative Site — St Louis, Missouri, United States
• Novartis Investigative Site — Omaha, Nebraska, United States
• Novartis Investigative Site — Omaha, Nebraska, United States
• Novartis Investigative Site — Henderson, Nevada, United States
• Novartis Investigative Site — Rochester, New York, United States
• Novartis Investigative Site — High Point, North Carolina, United States
• Novartis Investigative Site — Lake Oswego, Oregon, United States
• Novartis Investigative Site — Portland, Oregon, United States
• Novartis Investigative Site — Austin, Texas, United States
• Novartis Investigative Site — Dallas, Texas, United States
• Novartis Investigative Site — Charlottesville, Virginia, United States
• Novartis Investigative Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.